Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter H Graham

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Journal of Medical Imaging and Radiation Oncology|August 14, 2012
Digital photography as source documentation of skin toxicity: an analysis from the Trans Tasman Radiation Oncology Group (TROG) 04.01 post-mastectomy radiation skin care trialPeter H Graham, Natalie A Plant, Jennifer Louise Graham, et al.
The Prostate|March 12, 2014
CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistanceJie Ni, Paul J Cozzi, Jing L Hao, et al.
Plos One|August 8, 2012
In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147Jingli Hao, Michele C Madigan, Aparajita Khatri, et al.
BMC Cancer|October 11, 2015
Assessment of DNA methylation profiling and copy number variation as indications of clonal relationship in ipsilateral and contralateral breast cancers to distinguish recurrent breast cancer from a second primary tumourKatie T Huang, Thomas Mikeska, Jason Li, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 22, 2013
The complex relationship between lung tumor volume and survival in patients with non-small cell lung cancer treated by definitive radiotherapy: a prospective, observational prognostic factor study of the Trans-Tasman Radiation Oncology Group (TROG 99.05)David L Ball, Richard J Fisher, Bryan H Burmeister, et al.
Genome Integrity|August 4, 2010
Low levels of ATM in breast cancer patients with clinical radiosensitivityZhiming Fang, Sergei Kozlov, Michael J McKay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panelEwan K A Millar, Peter H Graham, Sandra A O'Toole, et al.
Cancer Research|November 29, 2017
miR-139-5p Modulates Radiotherapy Resistance in Breast Cancer by Repressing Multiple Gene Networks of DNA Repair and ROS DefenseMarina Pajic, Danielle Froio, Sheridan Daly, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2019
International comparison of cosmetic outcomes of breast conserving surgery and radiation therapy for women with ductal carcinoma in situ of the breastIvo A Olivotto, Emma Link, Claire Phillips, et al.
Asia-Pacific Journal of Clinical Oncology|November 29, 2019
Collaborative implementation of stereotactic ablative body radiotherapy: A model for the safe implementation of complex radiotherapy techniques in AustraliaEric Hau, Fiona Hegi-Johnson, Charlotte Atkinson, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Journal of Medical Imaging and Radiation Oncology|August 14, 2012
Digital photography as source documentation of skin toxicity: an analysis from the Trans Tasman Radiation Oncology Group (TROG) 04.01 post-mastectomy radiation skin care trialPeter H Graham, Natalie A Plant, Jennifer Louise Graham, et al.
The Prostate|March 12, 2014
CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistanceJie Ni, Paul J Cozzi, Jing L Hao, et al.
Plos One|August 8, 2012
In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147Jingli Hao, Michele C Madigan, Aparajita Khatri, et al.
BMC Cancer|October 11, 2015
Assessment of DNA methylation profiling and copy number variation as indications of clonal relationship in ipsilateral and contralateral breast cancers to distinguish recurrent breast cancer from a second primary tumourKatie T Huang, Thomas Mikeska, Jason Li, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 22, 2013
The complex relationship between lung tumor volume and survival in patients with non-small cell lung cancer treated by definitive radiotherapy: a prospective, observational prognostic factor study of the Trans-Tasman Radiation Oncology Group (TROG 99.05)David L Ball, Richard J Fisher, Bryan H Burmeister, et al.
Genome Integrity|August 4, 2010
Low levels of ATM in breast cancer patients with clinical radiosensitivityZhiming Fang, Sergei Kozlov, Michael J McKay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panelEwan K A Millar, Peter H Graham, Sandra A O'Toole, et al.
Cancer Research|November 29, 2017
miR-139-5p Modulates Radiotherapy Resistance in Breast Cancer by Repressing Multiple Gene Networks of DNA Repair and ROS DefenseMarina Pajic, Danielle Froio, Sheridan Daly, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2019
International comparison of cosmetic outcomes of breast conserving surgery and radiation therapy for women with ductal carcinoma in situ of the breastIvo A Olivotto, Emma Link, Claire Phillips, et al.
Asia-Pacific Journal of Clinical Oncology|November 29, 2019
Collaborative implementation of stereotactic ablative body radiotherapy: A model for the safe implementation of complex radiotherapy techniques in AustraliaEric Hau, Fiona Hegi-Johnson, Charlotte Atkinson, et al.
Pageof 6